Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus.
暂无分享,去创建一个
Kai Xu | Michelle L Colgrave | C. Broder | W. Michalski | K. N. Bossart | Kai Xu | D. Nikolov | M. Colgrave | B. Shiell | Wojtek P Michalski | Dimitar B Nikolov | Yan-Ru Feng | Yee-Peng Chan | Christopher C Broder | Katharine N Bossart | Hayley J Snelling | Brian J Shiell | Y. Chan | Yan‐Ru Feng | K. Bossart
[1] D. Stuart,et al. Dimeric Architecture of the Hendra Virus Attachment Glycoprotein: Evidence for a Conserved Mode of Assembly , 2010, Journal of Virology.
[2] R. Lamb,et al. Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures , 2005, Virology.
[3] C. Broder,et al. Receptor Binding, Fusion Inhibition, and Induction of Cross-Reactive Neutralizing Antibodies by a Soluble G Glycoprotein of Hendra Virus , 2005, Journal of Virology.
[4] M. Jones,et al. Peptide map analysis of recombinant human granulocyte colony stimulating factor: elimination of methionine modification and nonspecific cleavages. , 1994, Analytical biochemistry.
[5] V. Panin,et al. Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes. , 2010, Seminars in cell & developmental biology.
[6] D. Stuart,et al. Cells under siege: Viral glycoprotein interactions at the cell surface , 2011, Journal of structural biology.
[7] R. Dutch,et al. Role of N-Linked Glycosylation of the Hendra Virus Fusion Protein , 2005, Journal of Virology.
[8] C. Broder,et al. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats , 2008, Vaccine.
[9] Z. Shriver,et al. Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product. , 2011, Journal of pharmaceutical and biomedical analysis.
[10] J. Peter-Katalinic,et al. Methods in enzymology: O-glycosylation of proteins. , 2005, Methods in enzymology.
[11] Pan-Jun Kim,et al. Centralized Modularity of N-Linked Glycosylation Pathways in Mammalian Cells , 2009, PloS one.
[12] K. Mehta,et al. N-linked glycosylation of CD38 is required for its structure stabilization but not for membrane localization , 2006, Molecular and Cellular Biochemistry.
[13] N. Sharon,et al. Protein glycosylation. Structural and functional aspects. , 1993, European journal of biochemistry.
[14] C. Broder,et al. Identification of Hendra Virus G Glycoprotein Residues That Are Critical for Receptor Binding , 2007, Journal of Virology.
[15] The N-terminal 22 amino acids encoded by the gene specifying the major secreted protein of vaccinia virus, strain Lister, can function as a signal sequence to direct the export of a foreign protein. , 1992, Virus research.
[16] Joseph Zaia,et al. Mass spectrometry and glycomics. , 2010, Omics : a journal of integrative biology.
[17] B. Eaton,et al. The Exceptionally Large Genome of Hendra Virus: Support for Creation of a New Genus within the FamilyParamyxoviridae , 2000, Journal of Virology.
[18] G. Simmons,et al. Viral Entry into Host Cells , 2013, Advances in Experimental Medicine and Biology.
[19] S. Strahl,et al. Protein O-mannosylation: conserved from bacteria to humans. , 2009, Glycobiology.
[20] Kai Xu,et al. Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3 , 2008, Proceedings of the National Academy of Sciences.
[21] C. Broder,et al. Hendra and Nipah viruses: pathogenesis and therapeutics. , 2005, Current molecular medicine.
[22] Barbara Imperiali,et al. Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems. , 2006, Glycobiology.
[23] H. Field,et al. Nipah virus: a recently emergent deadly paramyxovirus. , 2000, Science.
[24] D. Jarvis,et al. Letter to the Glyco-Forum: Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities , 2011 .
[25] R. Lamb,et al. Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. , 2008, Virology.
[26] S. Brooks. Appropriate glycosylation of recombinant proteins for human use , 2004, Molecular biotechnology.
[27] Barbra A. Richardson,et al. Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses , 2007, Journal of Virology.
[28] Randy J. Read,et al. Dauter Iterative model building , structure refinement and density modification with the PHENIX AutoBuild wizard , 2007 .
[29] David I Stuart,et al. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2 , 2008, Nature Structural &Molecular Biology.
[30] A. Varki,et al. Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.
[31] V. Shepherd,et al. Virus glycosylation: role in virulence and immune interactions , 2007, Trends in Microbiology.
[32] Meir Shinitzky,et al. Structural and functional aspects , 1994 .
[33] J. Epstein,et al. Nipah virus: Impact, origins, and causes of emergence , 2006, Current infectious disease reports.
[34] N. Callewaert,et al. N-glycosylation engineering of biopharmaceutical expression systems. , 2009, Current molecular medicine.
[35] Lin-Fa Wang,et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Broder,et al. Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine , 2006, Journal of Virology.